Related Experiment Video

Updated: May 23, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

The current state of targeted therapy in melanoma: this time it's personal

Keiran S M Smalley1, Grant A McArthur

  • 1The Programs of Cutaneous Oncology and Molecular Oncology, The Moffitt Cancer Center, Tampa, FL 33612, USA. Keiran.Smalley@moffitt.org

Seminars in Oncology
|April 10, 2012
PubMed

Insights

Targeted therapies targeting BRAF and KIT mutations show promise for treating metastatic melanoma. Understanding melanoma genetics is key to developing effective treatments for this heterogeneous cancer.

Area of Science:

  • Oncology
  • Genetics
  • Dermatology

Background:

  • Metastatic melanoma treatment remains challenging.
  • Recent advances in understanding melanoma genetics have revealed its heterogeneous nature.
  • Specific oncogenic mutations drive melanoma development and progression.

Purpose of the Study:

  • To discuss the genetics and etiology of cutaneous and noncutaneous melanoma.
  • To review preclinical and clinical data on emerging targeted therapy agents.
  • To highlight the impact of new therapies on melanoma patients.

Main Methods:

  • Review of recent scientific literature on melanoma genetics.
  • Analysis of preclinical and clinical data for targeted therapies.
  • Discussion of BRAF and KIT mutations as therapeutic targets.

Main Results:

  • Activating mutations in BRAF and KIT are viable therapeutic targets for specific melanoma subgroups.
  • Targeted therapy agents are beginning to show a positive impact on patient outcomes.
  • Melanoma is a complex disease driven by diverse genetic mutations.

Conclusions:

  • Targeted therapies offer new hope for melanoma patients.
  • Further research into melanoma genetics will drive the development of more effective treatments.
  • Personalized medicine approaches are crucial for managing this diverse cancer.

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.